| 货号 | 规格 | 价格 | 上海 | 北京 | 珠海 | 重庆 | 武汉 | 购买数量 |
|---|---|---|---|---|---|---|---|---|
V37756-1mg |
≥99% | ￥2350.00 |
货期：3-5天 | - | - | - | - |
|
V37756-5mg |
≥99% | ￥5630.00 |
货期：3-5天 | - | - | - | - |
|
V37756-10mg |
≥99% | ￥7790.00 |
货期：3-5天 | - | - | - | - |
|
V37756-25mg |
≥99% | ￥11200.00 |
货期：3-5天 | - | - | - | - |
|
V37756-50mg |
≥99% | ￥13800.00 |
货期：3-5天 | - | - | - | - |
|
V37756-100mg |
≥99% | ￥17500.00 |
货期：3-5天 | - | - | - | - |
|
V37756-500mg |
≥99% | ￥34800.00 |
货期：3-5天 | - | - | - | - |
|
| 靶点： | NMDA | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 体内研究： | UK-240455 is a potent and selective N-methyl D-aspartate (NMDA) glycine site antagonist. Following i.v. administration of UK-240455 to male rats, UK-240455 has a clearance of 12 mL/min/kg and a volume of distribution of 0.4 L/kg. The plasma concentration of UK-240455 decreases with an apparent half-life of 0.4 h. Analysis of urine (0 to 24 h) for unchanged UK-240455 indicates that 57% of the dose administered is excreted unchanged in the urine. The urinary clearance of UK-240455 in the rat is therefore 7 mL/min/kg. Following oral administration of UK-240455 to male rats, the apparent elimination half-life of UK-240455 from plasma following oral administration is 1.6 h. | ||||||||||||||||||||
| 参考文献： | 1. Webster R, et al. Pharmacokinetics and disposition of a novel NMDA glycine site antagonist (UK-240,455) in rats, dogs and man. Xenobiotica. 2003 May;33(5):541-60. | ||||||||||||||||||||
| 保存条件： | -20℃ | ||||||||||||||||||||
| 配置溶液浓度参考： |
|
||||||||||||||||||||
| 注意： | 部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
沪公网安备 31011702002021号
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
北京